InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Balo Andrew K, Directeur Médical. Insider active across 1 companies, notably DEXCOM INC. In total, 9 reports have been logged. Total volume traded: €1m. The latest transaction was disclosed on 8 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€54,984 shares@ €0.00090.0000% mcap0.0% of flow
Common Stock
SEC:0001093557-22-000045:0·
€294,727683 shares@ €431.51770.0012% mcap58.5% of flow
Common Stock
SEC:0001093557-21-000195·
€294,727683 shares@ €431.51770.0012% mcap29.2% of flow
Common Stock
SEC:0001093557-21-000195:0·
€209,460578 shares@ €362.38720.0008% mcap41.5% of flow
Common Stock
SEC:0001093557-21-000177·
€209,460578 shares@ €362.38720.0008% mcap20.8% of flow
Common Stock
SEC:0001093557-21-000177:0·
9 of 9 declarations
About Balo Andrew K
Andrew K. Balo is Executive Vice President, Global Medical Affairs at Dexcom Inc. In this role, he oversees the company's medical and strategic initiatives. His expertise in the medical field is essential for the development of Dexcom.
